Cost-effectiveness analysis of hepatitis E vaccination strategies among patients with chronic hepatitis B in China.

Tingting CuiXuefeng ZhangQiang WangNa YueChangjun BaoRenjie JiangShilin XuZhaohu YuanYunke QianLiling ChenHui HangZhong ZhangHongmin SunHui Jin

Published in: Hepatology research : the official journal of the Japan Society of Hepatology (2023)

The disease burden in CHB patients superinfected with HEV is relatively heavy in China, and the screening-based hepatitis E vaccination strategy for CHB patients is the most cost-effective option. This article is protected by copyright. All rights reserved.

Keyphrases

end stage renal disease
ejection fraction
newly diagnosed
chronic kidney disease
peritoneal dialysis
hepatitis b virus
risk factors
patient reported